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ABSTRACT
A Computer Simulation Study of Blood
Cholinesterase Inhibition in
Parathion Treated Rats
by
Scott Christopher Hennes, Master of Science
Utah State University, 1980
Major Professor: Dr. Joseph C. Street
Department: Interdepartmental Program in Toxicology
A computer simulation model of blood cholinesterase inhibition
in rats resulting from a single oral or dermal dose of parathion was
developed and tested.

The model consists of a set of non-linear

differential equations describing the absorption, distribution and
metabolism of parathion and the kinetics of inhibition and reactivation of erythrocyte and plasma cholinesterase.

The equations are

numerically integrated to produce the time-course of each of the
cholinesterase activities of the blood.

The model was tested for

validity by a comparison of the activities predicted by the model
to values determined experimentally in male rats.

The model

successfully simulated plasma cholinesterase activity after a
four milligram per kilogram oral dose, and total blood cholinesterase
activity after a one milligram per kilogram oral dose.

Erythrocyte

cholinesterase activity was closely predicted for the first three
hours after a four milligram per kilogram oral dose, but inhibition
was overestimated during the next two hours.

Agreement between

model output and observed erythrocyte cholinesterase activity was

viii
good for the first twenty four hours after initiation of a fifteen
milligram per kilogram dermal dose, but the rate of activity regeneration was overestimated.

Es-timated erythrocyte cholinesterase

inhibition is sensitive to changes in the values of parameters
controlling liver paraoxon metabolism and the phosphorylation
reaction between paraoxon and the enzyme, but in general, the
model is not sensitive to small perturbations of parameter values.
The model has potential for interpreting human exposures to parathion
and for investigating the relationships between various parameters
and blood cholinesterase inhibition.

(80 pages)
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INTRODUCTION
Due to the hazardous nature of organophosphate insecticides,
there has been widespread interest in developing a suitable index
for human exposure to these chemicals.

One of the most widely used

indices is the extent of blood cholinesterase inhibition produced
by a pesticide exposure.

Blood cholinesterase inhibition is

reasonably well correlated with the level of organophosphate exposure
(Namba et al., 1971; Wills, 1972; and Long, 1975) and the response of
these enzymes co-varies directly with the intensity and duration
of absorption of the inhibiting chemical (Long, 1975).

Blood

cholinesterase depression is widely used in the monitoring and
regulation of occupational exposure to organophosphates, such
as the establishment of field reentry intervals for farmworkers
(Gunther et al., 1977).
Interpretation of blood cholinesterase activity measurements
could be aided by a quantitative description of the relationship
between the dose and the time-course of the response.

Two

principal strategies exist for formulating this description:
regression analysis and systems simulation.
Regression techniques have the advantage of s.imple mathematical
formulation and inexpensive application of the resulting model.
Serat (1973) presented a non-linear regression model relating plasma
cholinesterase activity to total chemical exposure of farmworkers
by use of a single first order differential equation.

Use of

this model requires either a fitting of the rate equation to actual
data on human plasma cholinesterase activities after exposure to

2

a particular insecticide, or the use of a dermal LD50 in rats.
The latter method requ;iores- an assumption that all insecticides have
the same ratio of rat dermal LDSO to the total chemical exposure
required to inhibit plasma cholinesterase in farmworkers by a given
amount (Sera t , 19 75) .

A systems analysis approach has several advantages (Innis, 1977).
It utilizes system knowledge that takes forms other than data
and is therefore more likely to yield useful approximations at
some distance from the data base.

It provides a rejectable set

of hypotheses about mechanisms that operate within the system and
also provides a simulated system upon which experiments can be
performed.

Garfinkel (1977) noted that simulation can quantify

relationships among variables and show how important they are
compared to other relationships in the same system, and in addition
can aid in experimental design.
The objective of this study was to use the systems approach
to develop a computer simulation model to predict plasma (ChE) and
erythrocyte (AchE) cholinesterase inhibition in male rats resulting
from parathion exposure, and to use the model to investigate the
relationship between blood cholinesterase inhibition and the
various parameters which control it.

The model organism and the

model insecticide were chosen because of the large literature data
base that exists on the effects of parathion exposure upon rats.

3

METHODS

Model Structure
The construction of th_e II!Odel was based on the following
assumptions:
1)

Parathion is metabolized in the liver by two pathways:
desulfuration, which yields paraoxon (Neal, 1967), and
dearylation which yields p-nitrophenol and 0,0-diethyl
phosphorothioic acid (Nakatsugawa and Dahn, 1967; Neal,
1967; Nakatsugawa

~

al., 1969).

Liver parathion is

exchanged with the blood by a flow-limited distribution
process.
2)

Blood parathion is exchanged with fat and muscle tissues
(Gagne and Brodeur, 1972) by a flow limited distribution
process.

3)

Parathion is absorbed from the gut through two processes:
gastric emptying and subsequent absorption from the
intestine by passive diffusion (Romankiewicz and Reidenberg,
1978).

Absorption from the skin is by a simple passive

diffusion process (Dugard, 1977).
4)

Paraoxon in the liver is subject to deethylation which
yields monoethylparaoxon and to hydrolysis which yields
diethylphosphoric acid and p-nitrophenol (Appleton and
Nakatsugawa, 1977).

Another route of paraoxon inactivation

is the reaction with tissue proteins to form phosphorylated

4

proteins (Lauwerys and Murphy, 1969a, 1969b; Triolo et al.,
1970; Benke and Murphy, 1974).

Phosphorylated proteins can

spontaneously reactivate (Levine and Murphy, 1977).

Liver

paraoxon is exchanged with the blood by a flow-limited
distribution process.
5)

Blood paraoxon is hydrolyzed to diethyl phosphoric acid
and p-nitrophenol by plasma A-esterases (Aldridge, 1953),
and inactivated by reactions with plasma proteins (Lauwerys
and Murphy, 1969a; Silvestri, 1972; Schoenig, 1975), and
blood cholinesterases

(Aldr~geand

Reiner, 1972).

Phosphor-

ylated plasma proteins can spontaneously reactivate (Levine
and Murphy, 1977).

Paraoxon is exchanged with fat tissues

(Gagne and Brodeur, 1972) by a flow limited distribution
process.
6)

Blood cholinesterases are inhibited by a reaction with
paraoxon which yields a phosphorylated enzyme (Aldridge and
Reiner, 1972).

The enzymes may revert to the active form by

hydrolysis to release diethyl phosphate or may undergo
a deethylation of the phosphoryl moiety to form a nonreactivatable (aged) enzyme (Hobbinger, 1963).

Plasma

cholinesterase is replaced by new enzyme synthesized in the
liver (Wills, 1972; Murphy, 1975); erythrocyte cholinesterase
is regenerated by turnover and replacement of the red
blood cells (Berlin and Berk, 1975; Murphy, 1975).

5

The assumptions were formulated into a set of simultaneous
differential equations and coded into FORTRAN.

The five equations

describing parathion dynamics were solved analytically by obtaining
eigenvalues, eigenvectors and integration constants using numerical
procedures (IMSL, 1979).

Th.e remaining eleven equations were

integrated numerically by Gear's method for stiff equations (IMSL,
1979).

Es·timates of all model parameters except the dermal

absorption rate constant were obtained from the literature.

The

dermal absorption constant was estimated by a least squares fitting of
model output to erythrocyte cholinesterase activities obtained from
rats during a 12 hour, 10 mg/kg dermal parathion exposure (described
later in this section) by a gradient search technique (IMSL, 1979).
Estimation procedures for parameters whose values were not explicitly
available from the literature are detailed in Appendix B.
Model sensitivity analysis
Model sensitivity was studied by individually varying each
parameter by ±25% and observing the relative change in 6 selected
model responses.

The responses were minimum plasma and erythrocyte

ChE activities, times when these minimum activities occurred, and
maximum plasma parathion and paraoxon concentrations.

A simulated

oral dose of 2 mg/kg was used, a~d model responses were studied for
a 13 hour interval.
Selected parameter interactions were studied by factorial
arrangements of parameter value combinations using the previously
listed model responses.

The results were analyzed by analysis of

variance for a completely randomized design involving a full

6

factorial tre.;ttment arrangement without replication, using the
mean squares associated with the 3-way interaction to estimate
experimental error.

The 0.05 level of probability was used as

the criterion of significance.
Dermal exposure study
Analytical standard grade parathion (99

+ % pure) was provided

by U.S. Environmental Protection Agency, Analytical Chemistry
Branch (Research Triangle Park, N.C.).

Adult male Sprague-Dawley

rats (250 - 300 g) were purchased from Simonsen Labs Inc. (Gilroy,
C.A.) and housed in individual metabolism cages.
The animals were divided into three treatment groups of
five rats each.

On the day before exposure bhe animals were

anesthetized with ether and the hair on the dorsal, mid-lumbar
region was removed with small animal clippers.

Parathion, at

10 or 15 mg/kg, was applied to the shaved area in an acetone
carrier of 150 - 200

~1

by a variable volume micropipette.

control group received only the acetone carrier.

The

The rats were

placed into restraining harness-and-collar assemblies as described
by Bartek

~

al. (1972) and allowed access to food for the 12 hour

duration of the exposure.

After 12 hours the remaining parathion

was removed by soap and water.
Blood was collected by tail clip in heparinized 100

~1

disposable micropipettes during ether anesthesia at 0, 2, 4, 8, 12,
24, 48, 72 and 120 hours following parathion administration.
Erythrocytes and plasma were separated immediately by centrifuging
for 5 minutes at 825 x gravity, prepared according to Serat et al.
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(1977), and frozen for subsequent analysis by a modification of
the pH Stat technique described by Serat

~

al. (1977).

The

titrant concentration was 0.003 M NaOH and sufficient NaOH was
added to the saline diluent to raise the pH of the erythrocytes
to nearly 8 before analysis.
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RESULTS

Model Structure
The structure of the model is presented in a Forrester diagram
in Fig. 1.

The formulation of the model into a set of differential

equations is given in Table 1.

The accommodation of two exposure

routes by the model required alternate sets of equations describing
absorption since oral absorption consists of two consecutive first
order processes transporting parathion into the hepatic portal system,
but dermal absorption consists of one first order process transferring
parathion directly into the systemic circulation.
Parameter and initial condition values used in the simulations
are listed in Table 3.

Parameters are those quantities whose values

do not change during a model run; initial values are the starting
amounts for variables whose values are altered during the course of a
simulation.
Model Validation
To test the validity of the model, results from model simulations
were compared with results obtained from experimental investigations.
The activities of AchE measured in rats dermally exposed for 12 hr to
15 mg/kg parathion are compared to model output from a computer
simulation of the exposure in Fig. 2.

Model output is in agreement

with experimental results for the first 24 hr after initiation of
exposure, with the exception of the 12 hr activity measurement.
This point appears to be high in relation to the 8 hr and 24 hr
activities (jn the 10 mg/kg exposure, the 12 hr activity was less than
the 24 hr activity).

The simulated regeneration of AchE activity

9 a

Fig. 1.

Forrester diagram of model structure.

Represented are

amounts of material (c:J ), material transfers between compartments
(~),parameters

(-E;-), auxiliary variables computed from several

parameters ( () ), controls on rates of transfer ( ~ ),and sources
and sinks for material ( C) ).
Table 3.

Parameter symbols are explained in
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TABLE 1

Differential Equations Describing Model Processes

a b

Derma l Do se
1)

d dPtSL = - (PSPO + PSH +

2)

d PSP
dt

~~)*
*

d dPtS F =(_QF ;PSFP)* PSP

!~MU

4)

d

5)

d PSS
dt

6)

d dPtOL = (PSPO) * PSL

7)

*

(PSABS)

(p~~L) *

d POP = (QL)
dt
VL

AKI
- ( ATN

~MSP)*

-(QM

- (POML +

*

d ESTL
_d_t_ = -

9)

d ESTLP =(POPL)
dt
VL

*

10)

d ESTP
_d_t___

11)

d ESTPP = (POPP)
dt
VP

12)

d POF = (QF
OFP\
dt
\
VP

·k

(POPP\

*

j

i<

POP

- ( CTN

-

* ESTP

(PKR)

*

POP

_ ( QF

*

VF

FOP)

.~

14)

d ACHEPR =(AKI)* POP
dt
VP

16)

d

~~EPR

=

(c;;)*

CKI

*

)
VP

*

CHE * POP

ESTP * POP

+(QF ;F FOP)

k

POF

i<

ESTPP

POF

)*

(SYN) -

-(p~:p) *

POP * ESTP - (PKR) * ESTPP

d ACHE =(NRBC * ACTV)-(NRBC
* ACTV
dt
LIFE
LIFE *
ACHEO

d CHE
dt

POP

ESTLP

•'<

+ (PKR)

13)

15)

+(~~)*

POL

ESTL + (PKR) * ESTLP

POL * ESTL

=-~}*POP

*

~~)*

POL

* ACHE

(p~~L) * POL

8)

PSS

PSMU

QF * OFP) 1< POP
VP

~

*

PSS

ESTL

* VP)

PSP

-(QF ;FFSP)* PSF

POL

>'<

*

+ (QM * MSP) * PSMU + (PSABS)
\
VN

=(QM ;PSMP)* PSP

-

PSP

* SMP + Qh\
- -QF VP SFP + QM VP
VPj
(

PSL

* FSP) * PSF
VF
3)

+(~)*

PSL

*

(CAT)

POP

*

ACHE

*

- (AKR + AAGE + NRBC
\
LIFE

-(~~I)*

CHE

CHE

ACHE -(AKI)* POP
VP

-

POP

*

CHE

*
*

*

ACHE

+ (AKR)

ACTV \ ' ACHEPR
ACHEO} >< •

+ (CKR) * CHEPR

(CKR + CAGE + CAT) * CHEPR

*

ACHEPR
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TABLE 1, Continued

Ora l Dose

l)

d dPtSL = -(PSPO + PSM +

2)

d PSP
dt

=(!!.1_)*

+~F
=-

Sa)

d PSI
dt

Sb)

d PSST = dt

a
b

PSL

\ VL

*

PSL

+(~)*
*

PSP

PSF

PSI

+(QM

+ (KG)

*

~MSP)*

+ (KA) *PSI

~) *

-(QF * SFP + QM
SMP +
VP
VP
VP

;/sP)*

(KA)

~)*

PSP

+(QF ;FFSP_\ * PSF
\

PSMU

PSST

(KG) "' PSST

Variable Symbols are explained in Table 2
Parameter symbols are explained in Table 3

)
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TABLE 2
State Variable Symbols

PSL

Liver Parathion

ESTP

Plasma Esterase

PSP

Plasma Parathion

ESTPP

Phosphorylated Plasma
Esterase

PSF

Fat Parathion
POF

Fat Paraoxon

PSMU

Muscle Parathion
ACHE

Erythrocyte Cholinesterase

PSS

Skin Parathion
ACHEPR

POL

Liver Paraoxon

Reactivatable Phosphorylated erythrocyte Cholinesterase

POP

Plasma Paraoxon
CHE

Plasma Cholinesterase

ESTL

Liver Esterase
CHEPR

ESTLP

Phosphorylated Liver
Esterase

Reactivatable Phosphorylated Plasma Cholinesterase

PSI

Intestinal Parathion

PSST

Stomach Parathion

TABLE 3
Model Parameters and Initial Values
Symbol

Parameter or Initial Value

Value Used

Reference a

AACT

AchE Activity

1. 7 units/ml

Wills (1972)

5

AAGE

Aging rate constant for AchE

1.1 x 10-

ACTVb

Units of AchE per erythrocyte

1.235 x 10-lO units/cell

AKI

Bimolecular reaction constant for
AchE-paraoxon

m1.n

units/cell

2~0 _£micromol/ml)

-1

Estimated by non-linear optimization on data from Vandekar &
Heath (1957)
Calculated from enzyme activity
and erythrocyte count
Estimated from Davison (1953)

AKR

Diethyl-phosphorylated AchE
reactivation constant

3.7 x 10-4 min -1

ATN

Turnover number for AchE with
acetylcholine

1 x 10

CACT

ChE activity

0.620 units/ml

Hills (1972)

CAGE

Aging rate constant for ChE

1.1 x 10 -5 min-1

Adopted from AchE aging rate

CAT

ChE catabolism constant

9.417 x 10 -5 min -1

CKI

Bimolecular reaction constant for
ChE-paraoxon

min

CKR

Diethyl-phosphorylated ChE
reactivation constant

82.~

2.30

4

units/micromol

1 (micromol/ml)
X

Estimated by non-linear
optimization on data from
Vandekar & Heath (1957)

10 -3

Berry (1951)

Estimated from Domschke et. al.
(1970)
---1

Estimated from Davison (1953)
Davison (1953)

I-'

w

TABLE 3, Continued
Reference a

Value Used

Symbol

Parameter or Initial Value

CTN

Turnover number for ChE with acetycholine 1 x 10

4

units/micromol

Adopted from AchE turnover number

-1

DEST

Rate of metabolic destruction of AchE

-5 min -1
1.157 x 10

ESTLb

Phosphorylatable liver protein

3.35 x 10

ESTPb

Phosphorylatable plasma protein

4.10 x 10

KA

Absorption constant for parathion
from the intestine

6.064 x 10

KG

Gastric emptying constant for corn oil

5.058 x 10

LIFE

Ery~hrocyte

86,400 min

NRBCb

Erythrocyte number

1.361 x 10

OFP
FOP

Distribution factors for
paraoxon in fat

1. 0
1.0

PSABS

Parathion dermal absorption constant

1.45 x 10

PKR

Phosphorylated protein reactivation
constant

2.30 x 10

POMLb

Paraoxon liver metabolism constant

13.77 min

POMPb

Paraoxon plasma metabolism constant

4.789 ml/min

Estimated by rat VM
Aldridge (1953)

POPL

Liver protein phosphorylation
constant

. -1
542 m1n

Adopted from plasma protein
phosphorylation constant

life span

-2

(Erythrocyte life span)

micromol

Estimated from Lauwerys & Murphy
(1969a)

micromol

Schoenig (1975)

-2
-3

min

-3

min

-1

Estimated by non-linear optimization on data from Schoenig (1975)

-1
Berlin & Berk (1975)

11

FASEB Biological Data Handbook
(1971)
Estimated from Gagne
(1972)

-4

-3

min

-1

min

-1

-1

&

Brodeur

Estimated by non-linear optimization on 10 mg/kg dermal dose
AchE data
Adopted from ChE reactivation
Estimated from Appleton (1976)

T rabbit

km

~

.p.

TABLE 3, Continued
Symbol

Parameter or Initial Value

Value Used

POPP

Plasma protein phosphorylation constant

542 min

PSMb

Parathion dearylation constant

5.79 min

-1

Reference a
Estimated from Silvestri (1972)

-1
-1

Estimated from Schoenig (1975)

PSPOb

Parathion desulfuration constant

11.77 min

QFb
QLb
QMb

Fat· "'plasma" flow rate
Liver "plasma" flow rate
Muscle "plasma" flow rate

0.48 ml/min
10.52 ml/min
5.69 ml/min

Calculat ed by power law equations
Lindstrom et . al. (1974) and
adjusted for parathion distribution into RBC.

SFP
FSP

Distribution factors for
parathion in fat

1. 378
-3
2.3 X 10

Estimated by non-linear oprimization on data from Gagne &
Brodeur (1972)

SHP
HSP

Distribution factors for
parathion in muscle

1.0
1.0

SYNb

ChE synthesis rate

1.89 x 10- 3 units/min

VFb

Fat volume

25.6 g

Calculated by equation from
Gagne & Brodeur (1972)

VLb
VMb

Liver extracellular fluid volume
Muscle volume

2.73 ml
116.48 g

Calculated by power law
equations. Lindstrom et. al.
(1974).
---

VPb

Plasma volume adjusted for parathion
distribution into RBC

13.55 ml

Calculated by equation from
Gagne & Brodeur (1974). Parathion distribution from
Schoenig (1975)

Estimated from Schoenig (1975)

CAT

*

Total blood ChE activity

·:Procedures for obtaining estimated values are detailed in Appendix B
Values which depend on rat body size are given for a 200 g rat
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appears to be more rapid than is experimentally observed.
The response of the model to a 4 mg/kg oral dose is compared to
plasma (Jig. 3) and erythrocyte (Fig . 4) activities measured in male
rats by

Skalsky~

al. (1979).

The predictions of plasma activities

are in excellent agreement with the experimental results.

Model

predictions are consistent with observed erythrocyte activities during
the 3 hr period immediately following the dose.

Over the next 2 hr

interval the predicted activities were lower than observed values.
Whole blood cholinesterase activities reported by Jacobsen et al.
(1973) for male rats orally dosed with 1 mg/kg parathion are presented
with corresponding model-simulated activities in Fig. 5.

Predicted

and observed results are quite similar at one and four hours after
dosing, but are different at 2.5 hr.
Sensitivity Analysis
Model parameters and initial values were varied individually by
±25% to study the relationship between each input and selected model
responses.
control

Response changes were measured as percentages of the

(~ith

all parameter values as given in Table 3) response.

Average responses were computed from the absolute values of the responses to increased and decreased input alterations, and these are
presented in Table 4 as fractions of the input perturbation i.e. 25%.
Only six indicators changed by amounts equal to or greater than the
input change.

These were:

maximum AchE inhibition and maximum blood

parathion and paraoxon concentrations in response to changes in dose;
maximum AchE inhibition and maximum blood paraoxon concentration in
response to changes in liver paraoxon metabolism constant (POML); and
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TABLE 4
Effects of Altering Model Parameters and Input Variables on Selected Model Output a b
RATIO OF OUTPUT CHANGE:INPUT CHANGE
ALTERED MODEL
PARAMETER DR
INPUT VARIABLE

MAXIMUM
ACHE
INH IB ITIDN

MAXIMUM
CHE
INHIBIT ION

TIME OF
MAX I l1UM ACHE
INHIBITION

Tit1E OF
MAXIMUM CHE
INHIBITION

MAXIMUM
BLOOD PARATHION
CONCENTRATION

MAXIMUM
BLOOD PARAOXON
CONCENTRATION

AACT
AAGE
AKI
AKR
ATN
Bl.J
CAGE
CACT
CAT
CKI
CKR
CTN
DOSE
ESTL
ESTP
KA1
KG2
LIFE
LIV
OFP
FOP
PKR
POML
POMP
POPL
POPP
PSMI
PSPO
SFP
FSP

0.11
0.01
1. 18
0.27
0.12
0.05
0.01
0.02
0.01
0.02
0.01
0.03
1.89
0.14
0.66
0.31
0.30
0.02
0.15
0.02
0.02
0.28
1.46
0.33
0.02
0.21
0.61
0.67
0.03
0.81
0.01
0.00

0.03
0.01
0.01
0.00
0.04
0.01
0.01
0.01
0.01
0.31
0.15
0.01
0.50
0.04
0.18
0.12
0.12
0.00
0.04
0.01
0.01
0.07
0.42
0.09
0.00
0.05
0.17
0.17
8.81
0.0 1
0.81
8 . 00

0.05
0.00
0.16
0.19
0.05
0.03
0.00
0.00
0.00
0.00
0.02
0.00
0.31
0.03
0.10
0.42
0.42
0.03
0.03
0.02
0.02
0.03
0.23
0.08
0.08
0.02
8.08
0.13
0 .02
0.00
0 . @0
8 . 03

0.04
0.06
0.06
0.06
0.06
0.06
0.04
0.08
0.06
0.08
0.23
0.02
0.08
0.02
0.08
0.40
0.40
0.06
0.06
0.06
0.04
0.11
0.08
0.08
0.08
0.86
0.08
0.06
8 . 06
0 . 06
0.11
0 . 06

0.00
0.00
0.00
0.80
0.00
0.13
0.00
0.00
0.00
0.00
0.00
0.00
1.00
0.00
0.00
0.49
0.49
0.00
0.00
0 .00
0.00
0. (~0
8.88
0.00
0.00
8.08
0. 33
0 . G8
0 . D?
0 . (~ I
8.82
0.84

0. 12
0.05
0.06
0.04
0.03
0.09
0. II
0.11
0. II
0.10
0.11
0.08
1. 66
0.12
0.55
0.56
0.57
0. 10
0. 11
0.08
0.89
0. 18
1.43
0.26
0.08
0 . 89
0.66
0 . 62

sr·tP
MSP

B. DB
0 .11
0.G6
0.03

:Parameter symbols are explained in Table 3 .
Changes are expressed as average percent difference from the value obtained with
unperturbed parameter values. Input change is + 25%.

N

t-'

22
maximum AchE inhibition in response to changes in AchE-paraoxon
bimolecular reaction constant (AKI).
To determine whether parameter errors can interact to yield
greater than additive effects on model output, a factorial arrangement
of parameter alterations was employed in an investigation of responses
of the selected indicators.

The parameters which caused the largest

changes in the indicators when varied individually (DOSE, POML, AKI)
were chosen to maximize the chance of detecting interactions (Snedecor
and Cochran, 1967).

Two levels of AKI and POML (±25% of unperturbed

value) and three levels of DOSE (1.5, 2.0 and 2.5 mg/kg) were

emplo~ed.

Two significant interactions were found, POML X DOSE on ChE minimum
activity and on maximum blood paraoxon concentration, and these are
presented as differences in the dose-response relationship at the two
levels of POML (Fig. 6).

These two interactions also yielded statis-

tically significant quadratic effects of DOSE but, as evidenced by the
straight lines in Fig. 6, these have no pnactical significance and
are the result of the very small error terms produced by simulation.
The interactions of the metabolism rate constants were also
investigated.

A 2X2X2 factorial arrangement of POML, PSM, and PSPO

was used and two significant interactions were found.

These interac-

tions, POML X PSPO and POML X PSM on maximum paraoxon concentration,
are presented in Fig. 7.
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DISCUSSION

A model predicting blood cholinesterase inhibition following
parathion exposure was constructed on the basis of a set of simplifying assumptions concerning parathion metabolism and distribution, and
cholinesterase inhibition and regeneration.

Although the model did

not give an exact simulation of the data at all times, it did
describe the proper dynamics of inhibition with the conditions
under which it was tested.

The model adequately predicticted AchE

activities for the first 24 hours with a 12 hour dermal parathion
dose.

Model output closely agreed with plasma cholinesterase

activities over the entire time span following an oral dose, and
corresponded well with AchE activities for the first three hours.
Total blood cholinesterase activity following a low oral dose was
predicted well by the model.
Many of the parameters required for the model have not been
adequately investigated experimentally, the therefore had to be
estimated for the purposes of this study.

A comprehensive mathematical

description of the type presented here reveals areas in need of
additional research effort for a better understanding of the operation
of such a system.

A model sensitivity analysis can be the guide to

the relative degree of effort that should be expended on the
investigation of the various parameters.
Disagreement between the model and experimental data was observed
for AchE regeneration upon termination of the dermal dose.
have resulted from an improper aging rate constant.

This may

Data from

Vandekar and Heath (_1957) on AchE activity regeneration after exposure
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to a diethyl-phosphorylating compound (0,0-d:Lethyl S-ethylsulphonioethylmethyl phosphorothiolate) were used to estimate the aging rate
by a least squares fitting procedure.

Although diethyl phosphoryl-

ated AchE is known to undergo an aging reaction (Aldridgeand Reiner,
1972; Mehratra and Singh, 1972), observed AchE reactivation in vivo
was log-linear to virtually complete reactivation at 28 days, indicating little or no aging; use of this data set probably caused an
underestimation of the aging rate.

When the aging rate reported for

rat brain cholinesterase (Mehrotra and Singh, 1972) was substituted
into the model (a 100 fold increase in the parameter value) the
simulated activity regeneration underestimated the observed results.
Interpretation of these results is complicated by uncertainties about
the completeness of skin parathion removal by soap and water washing,
although the agreement between predicted and observed values at 24
hour indicates an adequate cessation of exposure.
In the later stages of AchE inhibition follow-ing an oral dose,
the model predicted lower activities than were actually observed.
This could be due to an underestimate of the paraoxon liver metabolism
constant.

The constant was estimated from data derived from a study

of paraoxon metabolism resulting from a "first pass" infusion of
paraoxon into the liver (Appleton, 1976), a situation which omits the
effect of the subcellular proximity of the paraoxon formation and
degradation enzyme systems in promoting degradation (Nakatsugawa
and Morelli, 1976).

In addition, the effect of P450 binding by

reactive metabolites of parathion

(Neal,~

al., 1977) on the in

vivo desulfuration constant needs to be evaluated.
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A sensitivity analysis provides a measure of the model's behavior
or "robustness" (Levins, 1966) and an indication of the accuracy
required in various input data (Wiens and Innis, 1974).

From the

sensitivity analysis of the oral cholinesterase inhibition model
(Table 4), only six out of 192 measured responses exhibited a
relative change equal to or greater than the relative change in the
input value, and three of these were due to changes in dose.

More

than 90% of the responses had relative changes less than half of
the relative change in the input value.

In addition, only four

significant interactions between simultaneous parameter alterations
were detected out of 48 tested, and these four were rather small.
This demonstrates the general insensitivity of the model to errors
in most input valt.iable values and suggests that the model may be
relatively "robust".
The levels of all sensitivity indicators responded more strongly
to changes in dose level than to changes in any of the parameter
values.

The times for maximum AchE and ChE inhibition were most

responsive to changes in gastric emptying (KG) and intestinal absorption (KA) constants.

Maximum AchE inhibition and maximum blood para-

oxon concentration were the most sensitive indicators to input
changes; AchE bimolecular reaction constant (AKI) and paraoxon liver
metabolism constant (POML) alterations elicited larger responses
than any of the other parameter changes, with paraoxon concentration
responding strongly to the latter and AchE inhibition responding
strongly to both.

None of the indicators were very sensitive to

changes in parameters controlling parathion and paraoxon tissue
distribution.
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The use of blood cholinesterase inhibition me asur ements to
evaluate exposure to organophosphate insecticides·, and to det e rmine
farmwork e r re entry periods could be facilitated by the use of a
predictive model such as the one presente d here .

A quantitative

description of the relationship betwe en dose and the time-course
of the response would allow· estimation of the dose from the measurement of enzyme activities at several times .

The coupling of a model

describing environmental dynamics of insecticides w·i th a model
describing blood cholinesterase inhibition would facilitate evaluation
of the multitude

of factors which influence the time needed for a

s prayed field to become safe enough for human entry .

An effort to

adapt this- model to human exposure to parathion is now being conducted .
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Appendix A
Review of Literature

Organophosphate exposure index
Due to the hazardous nature of organophosphate insecticides,
there has been widespread interest in developing a suitable index
for human exposure to these chemicals.

One of the most widely

used indices is the amount of cholinesterase inhibition produced
by a pesticide exposure.

Since organophosphates produce their

toxic effects by inhibiting cholinesterases, measurements of the
activities of these enzymes serve as basis for an index of the
absorbed dose and of a biochemical response to the dose.
The cholinesterase-containing tissue that is most accessible
for monitoring is the blood.

There are two distinct types of

cholinesterases in the blood, erythrocyte cholinesterase (AchE) and
plasma cholinesterase (ChE), both of which may be measured to yield
an exposure index (Matsumura, 1975).

Since the cholinesterase in

erythrocytes is considered to be identical to the enzyme in
nerve tissue, AchE measurements are usually considered to be a r. better
index of toxicity (Murphy, 1975).

The amount of blood cholinesterase

inhibition is, however, only an indirect measure of the extent of
inhibition at the sites of toxic action, which are the cholinergic
neuronal synapses.
Blood cholinesterase inhibition is reasonably well correlated
with the level of organophosphate exposure (Namba et al., 1971;
Wills, 1972; Long, 1975).

Long (1975) reported that the response

of these enzymes co-varies directly with the intensity and duration

35
of absorption of the inhibiting chemical and that the specificity
is excellent in relation to AchE and · fair in relation to ChE.
Blood cholinesterase depression is widely used in the monitoring
and regulation of occupational exposure to organophosphates, such
as the establis.hment of field reentry intervals for farmworkers
(Gunther et al., 1977).

Quantitative models
An equation for calculating safe reentry periods based on
acceptable levels of cholinesterase depression has been reported
(Serat, 1973).

The equation combines a rate expression for the

loss of pesticide residues from the field with an equation describing
the rate of change of cholinesterase activity with cumulative
pesticide exposure.

The model assumes that cholinesterase activity

declines by a first order process in relation to pesticide
residues.

Data relating enzyme activity of exposed workers to the

cumulative pesticide residues to which they were exposed are
needed to calculate the first order rate constant.

An extension

of this model has been proposed which allows the calculation of
reentry intervals without data from human exposure (Serat et al.,
1975).

The model is based on the assumption that all pesticides

have the same ratio of the amount of pesticide exposure needed
to lower ChE activity by a given amount to the dermal Ln
female rats for the particular pesticide.
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of

A comprehensive literature

search did not reveal any additional predictive models of cholinesterase inhibition.
Lindstrom et al. (1974) presented a simulation model of
dieldrin distribution in mammals that was based on physiologically
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meaningful parameters (e.g. blood flow rates, biotransformation
rates and compartment sizes).

They concluded that such a mode l

is applicable to analysis of data, testing of hypotheses,
examination of experimental design and exposure of areas of
inadequate knowledge which require further research.
Garfinkel (1977) stated that simulation is valuable in
interpreting the behavior of complex biological systems.

It

can help quantify the observed relationships among variables and
show how important they are in comparison to other relationships
in the same system.

Simulation can also help in experimental

design such as in planning the quantitative manipulation of a
system.

Cholinesterase Inhibition
The reaction of organophosphates with cholinesterases has
been described as active-site directed irreversible inhibition
(Main, 1973).

The reaction scheme may he represented as:

EH

+

PX _

'

kl

k2

_,;.;;;._,~ EHPX---)~

EP

+

HX

(1)

k_l

where EH is the active, protonated enzyme, PX is an organophosphate
inhibitor, EHPX is an enzyme-inhibitor binding complex of the
Michaelis type, and EP is the irreversibly inhibited enzyme.

A kinetic treatment using Michaelis-Menten assumptions yields
a rate equation of:
dEP
dt

(EP])

[PX]

KD + (PX]

(2)

where KD is the inhibitor concentration required to yield half
the maximum rate of production of EP, and [E]t is the total concen-
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tration enzyme.

K
D

k_l

with an assumption of rapid equilibrium

k+
k

formation of EHPX; KD

+k

-1

k

2

with a steady-state formation

1

assumption.
Due to the low blood concentration of acetylcholine, the
protective effect of the competing substrate reaction against
enzyme phosphorylation is negligible in vivo.

This can be

demonstrated by an analysis of the equation presented by Hart and
O'Brien (1973) for enzyme phosphorylation in the presence of
substrate:
d[EP]

K [PX]
2

([E]~

- [EP])

1 - [S]

~~----

K

m

~

dt

+ [PX]

1 -

+ [S]

]
[PX]
[ ~ + [PX]

[S]
]
[ Km + [S]

The first term on the right side of the equation is the rate
expression for phosphorylation in the absence of substrate; the
second term is the modification of the phosphorylation rate
produced by the substrate reaction.

The effect of blood

acetylcholine can be seen by substituting appropriate values for
S (substrate) and K (substrate Michaelis constant).
m
Using a K value of 10
m

-4 M, which is the K for rat brain
m

AchE (Ho and Ellman, 1969), and aS value of 6.84 x 10-ll M
(Lipshits and Kratinova, 1977) the numerator acquires a value of
0.999999.

The size of the denominator varies according to the
[PX]
concentration of PX. If PX is very large, KD + [PX] will approach
one, and the denominator will approach the numerator.

If PX is
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[PX]
very small, K + [PX] will approach zero, and the denominator will
D

approach one.

Therefore, the value of the second term can be no

smaller than 0.999999, which is an insignificant diminution of
the phosphorylation rate.
Cholinesterase activity regeneration
Inhibited cholinesterase may revert to the active form by
hydrolysis of the diethyl phosphorylated enzyme (Aldridge, 1972).
The reaction releases diethyl phosphate, which is not inhibitory.
The rate of hydrolysis is dependent on the type of cholinesterase,
the temperature and pH of the reaction medium, and the nature of
phosphorylating group.

The reaction may be represented as:

EP

k3
+H 0
2

-~--)~

EH + POH

(4)

The rates of return of enzyme activity have been shown to be
the same in vivo

as they are in vitro (Davison, 1953; Vandekar and

Heath, 1957; Blaber and Creasy, 1960).

The amount of reactivation

that can be attained is inversely related to the elapsed time
after phosphorylation.

This is due to the "aging" of the enzyme,

which corresponds to a dealkylation of the dialkoxy phosphorylated
cholinesterase (Murphy, 1975).

The reaction is acid catalyzed

and follows first order kinetics (Hobbinger, 1963).
The rate of aging of diisopropyl fluorophosphate (DFP) inhibited
cholinesterase is so rapid that the return of cholinesterase activity
is due to resynthesis of new enzyme rather than to enzyme reactivation
(Murphy, 1975).

Plasma cholinesterase is replaced by new enzyme
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synthesized in the liver (Murphy, 1975; Wills, 1972) while
erythrocyte cholinesterase is regenerated by turnover and replacement
of the red cells themselves (Murphy, 1975; Berlin and Berk, 1975).
The rate of resynthesis of plasma cholinesterase does not appear
to be affected by paraoxon.

Domschke et al. (1970) reported a

stimulatory effect of soman on ChE synthesis by rat livers, but this
effect was not observed with paraoxon, dimethoate, or DFP. No reports
of the influence of parathion on the rate of erythrocyte turnover
have been found, but DFP is routinely used to measure red cell life
span in vivo, and it yields results similar to those obtained by
other methods (Berlin and Berk, 1975).

Parathion metabolism
Desulfuration of parathion to form paraoxon has been shown to
be the result of mixed function oxidase activity (MFO) (Nakatsugawa
and Dahm, 1967).

The liver is quantitatively the most important

site of paraoxon formation (Neal, 1967a), however, small amounts
are produced by the brain and lung which may be very important in
relation to toxicity (Poore and Neal, 1972).

Erythrocyte cholines-

terase inhibition appears to be related to the amount of paraoxon
produced by the liver, while brain AchE inhibition appears to be
related to the amount of oxon produced by the brain (Poore, 1972).
The aryl-phosphorus bond of parathion can be cleaved to form
diethylphosphorothioate and p-nitrophenol (Nakatsugawa and Dahm,
1967; Neal, 1967a), and this has been established as the major route
of direct degradation of parathion (Nakatsugawa

~

al., 1969; Gagne
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and Brodeur, 1972).

This reaction can be catalyzed by a MFO enzyme

that appears to be distinct from the enzyme that catalyzes desulfuration (Neal, 1967b).

It is also catalyzed by glutathione-S-aryl

transferase, a soluble liver enzyme (Hollingworth, 1973).

The

oxidative pathway appears to dominate, since parathion has been
shown to be a poor substrate for glutathione transferase enzymes
(Hutson~

1977).

al., 1972; Benke and Murphy, 1975; Levine and Murphy,

Plasma does not contain a parathion desulfurase or a para-

thionase (Alary and Brodeur, 1969).
Paraoxon metabolism
In

~ontrast

to parathion metabolism, a large number of processes

are involved in the degradation of paraoxon.

The major pathway was

previously considered to be the hydrolysis of the aryl-phosphate bond
by paraoxonases (Plapp and Casida, 1958; Neal, 1967a) and by
glutathione S-aryl transferase (Hollingworth et al., 1973; Benke
and Murphy, 1975).

Recent studies by Appleton (1976) of in situ

hepatic metabolism of parathion and paraoxon indicated that hydrolytic
mechanisms functioned at a much lower rate than oxidative deethylation.

He concluded that 0-deethylation is the primary hepatic

system of paraoxon degradation following parathion administration
in the male rat.

The role of liver paraoxonase may have been over-

estimated in the past because of:

the reliance on in vitro

procedures which may have allowed the expression of hydrolytic
activity which was not available in vivo, the instability of the
0-deethylase enzymes, inappropriate analytical procedures (the TLC
procedures commonly employed do not adequately resolve monoethyl
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paraoxon and diethyl phosphoric acid) or misinterpretation of urinary
diethyl phosphoric acid levels which may be largely attributable to
extrahepatic processes.
Another group of investigators has questioned the role of liver
paraoxonase activity in paraoxon metabolism in vivo.

Lauwerys and

Murphy (1969a) found that paraoxonase activity is the primary mode
of paraoxon inactivation by rat liver and plasma in vitro only
when high paraoxon concentrations (>10concentrations of paraoxon (10-

7

4

M) were used.

With lower

M), inactivation is primarily the

result of tissue binding (enzymatic hydrolysis accounts for less than
1% of the total inactivation by 10 rng of rat liver at 10

-7

M paraoxon).

This inactivation is completed very rapidly (<2.5 minutes) and the
amount that is inactivated is not affected by a four-fold increase
in the concentration of paraoxon.

The lower paraoxon concentration

is thought to be more realistic estimate of in vivo levels (Triolo
~

al., 1970; Gagne and Brodeur, 1972).

The binding of paraoxon by

liver and plasma has been shown to be an important protective mechanism against paraoxon toxicity.

Selective blocking of these sites

by tri-0-tolyl phosphate potentiates the toxicity and the inhibition
of AchE and ChE (Lauwerys and Murphy, 1969b).

The binding sites

have not been identified, but there is suggestive evidence that they
may be nonspecific tissue esterases (Murphy, 1975).
These enzyme systems could reasonably be expected to regain their
activity by synthesis and reactivation, and this may be important
with multiple exposures to parathion.
this time.

These rates are not known at

The reactivation rates for liver and plasma aliesterase

have been measured in mice, and they are much higher than the
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correspondi.n g rates for liver and plasma cholinesterase (Levine and
Murphy, 1977).

Aliesterases comprise a major fraction of the total

plasma es-t erase activity in rats. (lvills, 1972) and they do not
undergo an aging reaction (Jansz, 1959).
Parathion and paraoxon distribution
The distribution of parathion and paraoxon within the rat body
has not been well characterized.

A review of the literature

revealed only one distribution study of parathion.
Brodeur (1972) s·tudied the fate of
following an i.v. injection.
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Gagne and

P-parathion in adult male rats

The total radioactive material

recovered from the liver, kidneys and brain represented small fractions of the administered dose.

The peak amounts, expressed as

percentages of the dose were 3%, 1 - 2.5%, and 0.03% respectively.
Relatively important fractions of the administered dose were recovered
from the skeletal muscles as shown by the peak value of 10.5%.

The

only substances found in the abdominal fat tissue were parathion and
paraoxon.

Maximal quantities were reaches at 60 minutes and repre-

sented 9.2% of the injected dose.
The fat tissue may serve as a reservoir for parathion, accumulating it in the early stages, and releasing it to the blood in the
later stages of distribution (Gagne and Brodeur, 1972).

A fairly

good temporal correlation was found between the rise of parathion
in the liver and its disappearance in abdominal fat tissue.

The

concentration of parathion in fat tissue was much higher than that
in the plasma, but the paraoxon concentration was somewhat lower in
fat than in plasma.

The parathion concentration in muscle was lower
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than that in the plasma, and the paraoxon concentration was not
given.

The interaction between parathion and lipoproteins of rat

blood has been investigated (Skalsky and Guthrie, 1977).

Parathion

appears to bind to these proteins in a non-specific hydrophobic
manner.

Parathion therefore appears to be bound and transported

by blood proteins, but the significance of this finding in relation
to toxicity is unknown.
Excretion of unmetabolized parathion and paraoxon appears to
be negligible.

They have been reported as traces (0.5-2.0%) of

excreted materials in urine (Gagne and Brodeur, 1972).

Fecal matter

contained only 1.6% of the administered labelled parathion dose
after 96 hours in a study by Appleton (1976).
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Appendix B
Parameter and Initial Condition Calculations
In vivo liver metabolism constants
Derivation.
(PSP)

0 ut

(1)

= F(PSPI n )

Mass balance for in situ metabolism studies:
d(PSL) = QL (PSP)I - F QL(PSP)I - kM (PSL)
dt
n
n
et
At steady state:
0

= QL[(PSP)In- F(PSP) 1 n] ~et = QL(PS)In [1 - F]

~et (PSL)

1

(2)

(3)
(4)

(PSL)
Assuming that the concentration in liver capillary blood is the
same as the concentration leaving the liver (Gillette and Pang,

1977), and that there is a liver volume in equilibrium with the
capillary blood:

Substituting for PS
PSL

=

0 ut

VL
VP

PSL = PSPOut
VL
VP

(5)

PSL = VL PSP
0 ut
VP

(6)

:

VP F(PSP)In

=

VL

F(PSP)In

(7)

Substituting for PSL in Equation (4):
l11et = QL(PSP)In [1 - F]
VL (PSP)
k.

-'Met

Ah.brevia tions used.
(

)

Concentration

=

QL
VL

In

(8)

F
(9)
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PSP

Plasma parathion

PSL

Liver parathion

QL

Liver plasma flow rate

F

Fraction of parathion entering liver which exits
unmetabolized

k

-""Met

Observed metabolism constant

E

Hepatic extraction ratio

Cl
C

0

Apparent oral systemic blood clearance of total drug
Concentration

Discussion.

Equation (9) is equivalent to an expression for

apparent oral total drug clearance when all of the drug is metabolized
by the liver, presented by Wilkinson and Shand (1975).
Cl

=
0

QL

(Wilkinson and Shand, 1975)
E = 1 - F

(10)
(11)

Substituting forE in Equation (10):
(12)

It is also equivalent to an equation given by Gillette and Pang

(1977) for a drug constantly infused into the blood just before it
enters the organ in an isolated organ perfusion system in which
blood recirculates (a situation equivalent to an oral administration
of a drug which is metabolized in the liver and measured in systemic
blood).
F

Clearance

QL [ CInc - COut
Out

l

(13)

(Gillette and Pang, 1977)

(14)
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Clearance

QL [ ~In -1]

(15)

Out
Substituting identity for F into Equation (15):
Clearance

Clearance

QL [

= QL [

t-

(16)

1]

1 ; F

J

(17)

These two equations are expressed as clearance (ml/min) in
contrast to Equation (9) given above which is expressed as a rate
constant (min

-1

).

This distinction disappears when the rate of

metabolism is computed because the plasma concentration used with the
clearance equations is the same as the liver concentration used
to derive Equation (9).

This occurs because, with an oral dose,

the site of systemic blood sampling is after the tissue but before
the site of administration (Gillette and Pang, 1977).

The rate

equations can be shown to be equal:
d PSP
dt
d PSP
dt

(18)

apparent ]
[ clearance

Calculations.

*

plasma
]
[ concentration

Schoenig (1975)

~et.

*

[ liver ] (l 9 )
amount

reported the results of an

in situ hepatic metabolism study in which a steady-state input
concentration of parathion was achieved from oral absorption.

The

data were presented as hepatic portal vein (HPV) and inferior vena
cava (IVC) parathion concentrations, along with percent metabolism
via the diethyl phosphoric acid (DEPA) pathway.

Data from the two

dose levels were averaged and then used to compute an overall parathion
metabolism constant.

This constant was divided into the dearylation

and desulfuration pathways by use of the value for the DEPA pathway
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contribution.

1 - F

.82
4 6
.18 = .s

F

PSPO =

PSM

~~

(0.67) (4.56)

(20)

~

(3 . 05)

QL

VL (0.33) (4 . 56)

=

QL

(1 . 50) VL

(21)

(22)

Similar data were furnished by Appleton (1976) for hepatic
paraoxon metabolism.

He presented the amount of metabolites and

parent compound that exited the liver 1 to 2 minutes after a
simulated intraperitoneal injection of 2 mg/kg paraoxon (direct
application to exposed gut tissue and mesentery).

The data were

expressed as percentages of the total radioactivity exiting the liver.
The fraction of the total radioactivity that was paraoxon represents F.

1---=--£ = . 781
F

3.57

. 219

POML

(23)

QL

::x

3.57 VL

(24)

Plasma cholinesterase catabolism constant
Derivation.
d CHE
r;:
dt
= SYN -fAT

*

;!

CH~ (Rechcigl,

1971)

(25)

t

(26)

Solving the differential equation:
CHE (t)

=

SYN
[ SYN J -CAT
CAT CAT e

*

At steady state, from Equation (25):
SYN = CAT ;'' CHE

(27)

ss

Substituting for SYN in Equation (26):
CHE ( t)

CAT * CH~ss
= ------=CAT

[ 1 _ e-CAT

·k

t

J

(28)
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CHE (t) ::; l _ e -CAT
CHE
ss
Solve for CAT:
CAT

Converting percent

~

-ln

t

*

t

(29)

CHE (t)J -1
CHE
t
ss

(30)

activr,y t~ fractional activity:

CAT

-ln [

-

•

activit;] -1
100
t

J

(31)

Abbreviations used.
t
CHE

Time
ss

Steady state plasma cholinesterase activity

Discussion .

Domschke

~

al. (1970) measured the return of plasma

cholinesterase over 48 hours following a high dose of DFP.

Since di-

isopropyl phosphorylated cholinesterases do not reactivate due to a
high aging rate, the return of activity is solely by synthesis of new
enzyme (Murphy, 1975).

Inhibition was 100% at four hours, but

recovery had begun by 8 hours.
The activity at 48 hours was used to calculate CAT.

Four hours

was chosen as the time for initiation of regeneration in the absence
of further inhibition.
Calculation.
CAT = -ln

~ -· 2 iO~ ~S =~

5.65 x 10

-3

hr

-1

(33)

Plasma protein phosphorylation constant
Derivation.

The second order rate equation:
-d (EST)
dt

=

k (EST) (PX)

Integrating the rate equation:

k

= [(EST) 0 l-

(PX)

~

ln

t

(PX)~
~l_t]
(PX)

EST)
(EST)
0

(34)
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Abbreviations used.
(

Concentration

EST

Phosphorylatable plasma proteins

k

Second order rate constant

PX

Organophosphate inhibitor

t

Time
Discussion.

Silvestri (1972) measured amounts of paraoxon

inactivated by rat plasma in vitro.

Two concentrations of paraoxon

were used and measurements were made after one and fifteen minute
incubations.
The initial protein concentration was estimated by using
a value for plasma concentration of phosphorylatable sites obtained
from Schoenig (1975).

Silvestri's (1972) paraoxon inactivation data

were converted to reaction volume concentrations from a "per ml
plasma" basis by use of volume manipulation information provided
in the text.
The data were plotted by use of Equation (34) in the manner
suggested by Daniels and Alberty (1975), but a non-linear plot
resulted.

The fifteen minute data yielded lower estimates of K

than did the one minute data.
The estimates of K provided by the data from the one minute
incubations at both concentrations were averaged to provide the
estimate of POPP.

The higher estimate of K provided by the one

minute incubations was more consis.tent with results from in vivo
studies which implied that plasma protein phosphorylation was more
rapid than AchE phosphorylation.

These findings were:

1) 8% of
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plasma binding sites remained at 4 hours after a 3 mg/kg i.p.
injection (Lauwerys and Murphy, 1969a);

2) 20% of erythrocyte

cholinesterase activity remained at 4 hours after a 5 mg/kg i.p.
injection (Murphy, 1969).
Calculations.

Concentrations are in micromoles/liter.

0.40 micorgram/ml paraoxon:
1
[ 3. 114 7~ 1. 45 34 ]
-1
-1
k = 4.2987 - 1.4534 ln 4.2987 * 0.2662 = · 483 uM
min

(35)

0.80 microgram/ml paraoxon:
1

k = 4.2987

1.9684
2.907 ln [ 4.2987

*
*

2.907 ]
-1
-1
0.5766 = · 601 uM
min

POPP = 542 (micromole/ml)

-1

min

-1

(36)
(37)

Bimolecular reaction constants
Derivation.

-dd~EH)

= ki (EH) (PX)

(Matsumura, 1975)

(38)

Assuming pseudo-first order kinetics, and integrating t=O to
t and the enzyme level (EH)

to (EH) :
t

0

ln [ (EH) o ] = k. (PX) t
1
(EH)

(39)

t

Solving for k.]_ and substituting for the enzyme concentration
ratio:
k

i

::::

1

(PX) t

ln [ lPOO ]

(40)

If (PX) is the inhibitor concentration causing 50% inhibition
of enzyme
k.]_

ln 2
ISO t

(41)
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Abbreviations used.
(

)

Concentration

EH

Cholinesterase enzyme

PX

Organophosphate inhibitor

k.

Bimolecular reaction constant

t

Time

P

% enzyme activity

l

I

50

Inhibitor concentration causing 50% enzyme inhibition

EP

Phosphorylated enzyme

KA

Affinity constant for enzyme-inhibitor complex formation
Discussion.

The reaction between cholinesterase and paraoxon

is actually a reversible association followed by a non-reversible
phosphorylation rather than a simple bimolecular reaction as described
in the previous section.

The kinetics become bimolecular with an

assumption that KA >> (PX).

The necessary constants were not avail-

able from the literature; therefore, the rigorous kinetic equation
could not be used in this project.

I
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data from Davison (1953) were

used to calculate k. values for both enzymes.
l

Calculations.

AKI

0.693
7
[ 1.1 x 10 M] [30 min]

2.1 x 10

210 (micromo1es/ml)
0 · 693

CKI

[ 2 . 8 x 10 ·-

=

7

J [3 0

M

min

J

-1

=

min

5

-1
-1
M min

-1

(42)

1
8.25 x 10 4 M- min-l

82.5 (micromoles/m1)

-1

min

-1

(43)
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Plasma volume and flow rates
Parathion distribution between plasma and erythrocytes was
studied by Schoenig (1975).

With whole blood concentrations

ranging over three orders of magnitude, the fraction of parathion
in the plasma was consistently 78%.
Drugs contained within erythrocytes are available for rapid
exchange with the plasma (Wilkinson and Shand, 1975)· consequently
blood parathion behaves as if parathion were contained in a homogeneous plasma having a larger volume than the actual plasma volume.
The plasma concentration of parathion was computed in the model by
dividing total blood parathion by plasma volume and then multiplying
by a factor of 0.78.

The plasma flow rates in tissues were increased

by a factor of 1/0 . 78 to accommodate the larger apparent plasma
volume.

Liver volume
The mass of liver that was represented by VL was the portion
of liver water that was assumed to be in equilibrium with parathion
in the liver capillaries.

The liver extracellular fluid (ECF)

volume was chosen for VL because lipid-soluble molecules enter the
interstital fluid almost instantaneously during their passage
through tissue capillaries and cell membranes restrict the passage
of drugs to a greater extent than do the capillary membranes
(Goldstein et al., 1974).

This choice was further supported by the

results of a parathion distribution study (Gagne and Brodeur , 1972)
in which liver and plasma parathion concentrations were roughly
equal when liver parathion was divided by liver ECF volume.

56
Calculation .
VL = [ Liver mass ] * [ Liver fractional ]
water content
VL= [ Liver mass ]

·k

-1< [

ECF-plasma
Total body water

J (44 )

[ 0 . 75 ] -1' [0.35]

(45)

The fractional water content of rat liver was obtained from
the FASEB Biological Handbook (1971); the ECF , plasma and total
body water volumes were adopted from human data (Guyton, 1971).

Phosphorylatable liver protein
Paraoxon inactivation by rat liver homogenates has been investigated at low concentrations of paraoxon (Lauwerys and Murphy, 1969a,
1969b).

One gram of liver homogenate can inactivate 15.2 nanomoles

of paraoxon by a binding mechanism (Lauwerys and Murphy, 1969a).
There are no data on the amount of paraoxon bound per gram of liver
in vivo.
The availability of binding sites in vivo was estimated by
multiplying the in vitro availability by the fractional liver mass
that represents the volume of liver that is hypothesized to be in
equilibrium with plasma parathion.

Paraoxon fat distribution constants
The relationship between the concentrations of paraoxon in fat
and plasma is similar to the relationship between the concentrations
of parathion in muscle and plasma (Gagne and Brodeur, 1972).
Therefore the values of FOP and OFP were adopted from the corresponding values of MSP and SMP.

Parameter optimization strategy
Discussion.

Parameters were optimized by use of a modified
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Leve nberg-Marquardt algorithm for finding the minimum of the sum of
squa r es of the difference s b e twe e n model output and observe d data
(IMSL , 1979).

Parameter values we re constrained by estimated upp e r

a nd lower bounds (IMSL , 1979).

In some cases , starting points for

th e optimization algorithm were generated by use of a program which
s y st e matically placed points to optimize their dispersion within
chosen bounds (IMSL , 1979).
1) to obtain a data set of observed

The general procedure was:

values corresponding to the model response(s) of interest;

2) to

a llow a set of model parameters which control the response(s) to
vary s imultaneously within specified bounds; and

3) to explore this

parameter space to find the combination of values which minimize s
th e difference(s) between model output and observed data .
The following parameters were optimized in this fashion:

AAGE,

AKR, KA, KG , PSABS , FSP , SFP , MSP , and SMP.

Acet y lcholinesterase aging and reactivation constants
Derivation.
d ACHE
dt

CSO +

[AKR *

d ACHER
dt
d ACHEPR
dt

ACHEPR] - [ DEST
AKR

=

*

-ClS

*

~CHER ]

(47)

ACHEPR

*

(46)

ACHEPR

(48)

Solving the system by an eigensystem procedure:

ACHE~

ACHEI + [ C50

*t]

+ ACHEPRI [

-DESTC~SAKR *

[DES~l;C::R +

AKR

l]

t + [1- e-ClS * t]

(

49 )
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ACHEPRI
Cl5

ACHER

ACHEPR

=

*

G
1 -

AKR

*

ACHEPRI

e

*

e -Cl5

-Cl5

*

tj

(50)

t

(51)

Abbreviations used.
ACHE

Total amount of active enzyme at time

ACHER

Amount of active enzyme at time

=

=

t

t that exists as a result

of reactivation of inhibited enzyme after time

=

ACHEPR

Amount of reactivatable inhibited enzyme at time

ACHE I

Total amount of active enzyme at time

ACHEPRI

Amount of reactivatable inhibited enzyme at time

ACHEO

Total amount of enzyme

Cl5

luZR

C50
t

'+ AAGE

=

0
t

0
0

.

+~- DEST

'-NRBC ,,_ ACTVJ L
LIFE

.[DEST

-1<

ACHEI]

Time
Discussion.

The closed form solution was used to calculate

the regeneration of enzyme activity.

Model output was optimized

against erythrocyte cholinesterase activities measured in rats at
intervals following 0,0-diethyl S-ethylsulphonioethylmethyl phosphorothiolate (Vandekar and Heath, 1957), a compound which yields diethyl
phosphorylated enzyme.

Two hours was selected as the starting time

for regeneration because enzyme activity began to increase after
this time.

The average amount of inhibited enzyme during the two

hours immediately following exposure was allowed to age for two
hours to establish a value for ACHEPRI.
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Intestinal absorpti_on artd gastr :t c ·emptying constants
Deriyq.tion.
d PSI = [-KA
dt
d PSST
dt

*

*

PSI] + TKG

*

= -KG

PSST]

(52)

PSST

(53)

Solving the system by an eigensystem procedure and substituting
DOSE for PSST (0) and 0. 0 for PSI (0):
PSI(t)

= DO~: ~g

G-KG *

Rate of absorption
Discussion.

=

KA

*

t

- e

-KA

*

JJ

(54)

(55)

PSI (t)

The closed form solution was used to calculate

parathion absorption rates following a 6 mg/kg dose.

Model output

was optimized against absorption rates measured in rats following
a 6 mg/kg po injection of radiolabelled parathion dissolved in corn
oil (Schoenig , 1975).
Dermal absorption constant
The entire simulation model was used to calculate erythrocyte
cholinesterase activity for a twelve hour dermal 10 mg/kg parathion
exposure.

Model output was optimized against erythrocyte cholines-

terase activities measured in rats at 2, 4, 8 and 12 hours during a
dermal 10 mg/kg parathion exposure (data collected as part of this
investigation).
Parathion distribution constants
The first four equations in the simulation model (parathion
system state variables), which are soluble by eigensystem analysis,
were us-ed to calculate amounts of parathion in liver, plasma, fat,
and muscle follow-ing a 3.1 mg/kg iv dose of parathion (the total
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dos-e was placed into the plasma at time= 0).

Model output was

optimized against parathion concentrations in liver, plasma, fat
and muscle measured in adult male rats following a 3.1 mg/kg i.v.
injection of 32 P-parathion (Gagne and Brodeur, 1972).
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Appendix C
Computer Program Listing

C PROGRAM CHESIM

c
c PRO GRAMMER-SCOTT HENNES
c DATE OC TOBER 1979
c
c DESCRIP TI ON-THIS PROGRAM SI MUL ATES PARATHION METABOLISM AND CHOLINESTERASE
c INHIBITION IN RATS. THE SYS TEM IS REPR ESE NTED BY A NON-LINEAR SYSTEM OF
c DIFFERENTI AL EQUATIONS. THE 6 EQUATIO~IS REPRESENTING PARATHION DYNAMICS
c ARE SOLVE D IN CLOSED FORM CLINEAR SUBSYSTEM) BY FINDING EIGENVALUES.
c EIGE NVECTORS . AND INTEGRATION CONS TANTS . THE 11 EQUATIONS REPRESENTING
c PARA OXON -CHOLINESTESASE DYNAMICS ARE NUMERICA LLY INTEGRATED BY GEAR'S
c METHOD FOR STIFF SYSTEMS . THE 2 LINEAR CHO LI NESTERASE REGE NERAT ION
c SUBSYSTEMS ARE REPRESEN TED BY CLOSE D FORM SOLUTIONS AFTER THE INHIBITION
c PERIOD HAS ENDED.
c
C SUBROUTINES- EIGRFCIMSL-7) TO CALCULATE EIGENVALUES ~ND EIGENVECTORS
C
LEQTlFCIMSL-7) LINEA R EQUATION SOLUTION FOR INTEGRATION C'S
DGEARCIMSL-7) DIFFERENTIAL EQUATI ON SOLVER
C

c
c
c

c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
c
C
C
C

S'r'MBOL DESCRIPTION
BW=BODY WE IGHT CGRAMSl
VPl=VOLUME OF PLASMA IN A RAT Cml)
VP=VO LU ME OF PLASMA. ADJU STED FOR PARATHION DISTRIBUTION WITHIN BLOOD (ml)
LIV=FRACTION OF LIVER WATER WHICH IS VOLUME OF DISTRIBUTION
VL=VOL UME OF DISTRIBUTION IN LIVER (mil
VF=VOLUME OF FAT (g)
VM=VOL UME OF MUSCLE Cg)
DL=LIVER PLASMA FLOW RATE--USING VP Cml/min)
QF=FAT PLASMA FLOW RATE--USING VP Cml/min)
QM=MUSCLE PL ASMA FLOW RATE--USING VP Cml/min)
FSP=EQUILIB RIUM CONCENTRATION COEF FICIENT FOR PARATHION IN FAT
FOP=
PA RAOXON IN FAT
MS P=
PARATHION IN MUSCLE
PSABS=DERMA L ABSORPTION RATE CONSTAN T FOR PARATHION (/min)
PSPO =PARATHION DESULFURAT ION RATE CONSTANT Vm in)
PSM=PARATH I ON DEARYLATI ON RATE CONSTANT Vm in)
POML=PARAOXON LI VER ME TABOL ISM RATE CONSTANT (/min)
POMP =
PLAS MA
(ml /m in)
AN I AFTER A VAR IAB LE NA ME ON INPUT INDICA TES A VALU E USED TO COMPUTE THE
VAR IAB LE IN THE PROGRAM
POP P=PLASMA PROTEIN PHOSPHORYLATi ml RATE CONSTANT VCMICROMOL/ml) min)
POPL=LIVER
PKR=PHOSPHORYLATED PROTEIN REACTIVATION CONSTANT (/m in)
HCT=HEMATOCR IT--AS A FRACTION
AACT= ACHE AC TI VITY CUNITS / ml RBCl
ACTV=ACTI VITY PER RBC CUNITS/CELLl
ACHEO =INITIAL TOTAL ACHE AC TIVITY (UNITS)
NR BC =NUMBER OF RBC PER RAT
LIFE=LIFETIME OF A RBC Cmi nl
AK I =B !MOLECULAR REACT ION CONSTANT FO R ACHE-PA RAOXON (/(MICROMOL/MU MIN)
AKR=ACHE RE ACTIVATION CO NSTAN T (/min)
AAGE=ACHE AGIN G RATE CONSTANT (/min)
ATN =TURNOVER NUMBER FOR ACHE WITH ACETYLCHOLINE CUNITS/MICROMOL)
CACT=CHE ACTI VITY CUN ITS/ml PLASMAl
CKI= BI MOLECU LA R RE ACTION CONSTANT FOR CHE-PAR AO XON (/CMICROMOL/ml)min)
CKR =C HE RE ACTIVAT ION CO NSTANT (/ min)
CAGE=CHE AG ING CONSTANT (/ mi n)
CTN=TURNOVER NUMB ER FOR CHE WITH ACETYLCHOLINE CUNITS/MICROMOL)
CHEO=IN IT IA L TOTAL CHE ACTIVITY CUNITSl
SYN=ZERO ORDER RATE OF ·cHE SYHTHESIS CUNITS / minl
TYPE =THE ROU TE OF ADMINISTRATION; EITHER 'ORAL', 'SKIN'. OR 'IV'
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80 1
803
804
805
806
808
900

901
902
903
904
905
906
907
908
909
910

911

912
91 3
914
91 S

91 6

919
917
920
921
922
92 3
924
92 5
926
927
928

FORMATCA4 )
FORMATC2F2. LF5.4,F2. LF6.5 ,6F2 .D
FORMATCJl)
FORMATC 4ll)
FORMATC2ll)
FORMA TC5CE8 .4),/5C5 CE8.4)/) ,/5 CE8 .4))
FORMA TC'0 BODY WEIGHT:' .F6. 1/'0 LIV ~ ',F6.3/'0 FSP = '.F7.4/
1'0 FOP = ',F6.3 / '0 MSP = ' ,F6 . 3/'0 PSPOI = '
2F6.3/'0 PS MI = ',F6.3/'0 POMLI = ',F6.3/'0 POMP! • ',F6.3/
3'0 POPP = ' , FS.l/'0 POPL = '. FS .l /'0 PKR = '.FB.S/'0 HCT
'.F6.3/
4·· 0 AAC T = ' ,F6.3/'0 LIFE = '.F?.l/'0 AKI = '.E11.4/
S'0 AKR = 'El0.3/'0 AAGE = ',FB.S/'0 ATN = ',E9.2/'0 CACT = ',F6.3)
FORHATC'0 CKI = '.FS.l/'0 CKR = ',FB. S/'0 CAGE= ',FB.S/
1'0 CTN = ·' J PE9 .2 /'0 SFP = 'E1 5 .5/'0 SMP = 'E15.5/'0 OFP = 'E1S.5/)
FORMATC'0 PARATHION SYSTEM IN ITIAL STATES'/'0',6CF5.2,5X)/)
FOR~1ATC'0 PARAOXON SYS TE ~1 INITIAL INPUTS' / '0' ,2 CF4. LSX)/
1'0 YC 3) = ' . F7.4/'0',F4.l/'0 YC 5) = ',F8.5/'0',6CF4.1,5X)///)
FORMA T(' 0 SWICH 1 ~ ·· ,I 1. 10X. 'SWICH2 = ',I 1///)
FO RMAT C' 0 THE COEFFICIENT MATRIX A FOR THE PS SYSTEM'
1' OF LINE AR DIFFERENTIAL EQUATIOHS',//'0',6C6ClPE10.3,5X)//))
FORMATC'0 THE EIGEN VALUES OF MATRIX A:',//'0',
16C1 PE 10.3,E8.1,3X)///)
FORMATC'0 THE EIGEN VE CTORS--COLUMN J CORRESPONDS TO EIGENVLAUE J',
1// '0',6C6C1PE10.3,E8.1,3 X)//)///)
FORMA TC'0 L • ',2I,SX,'IF L IS GREATER THAN 0, THERE ARE'
1' IMAGINARY OR MULTIPLE EI GENVA LUES AND THE RUN WILL TERMINATE'///)
FORMATC'0 THE INTEGRA TION CONSTANT VECTOR '6C1PE11.4,5X)/'0 IER ='
1 IS / ' 0 I DGT = ' , I 1/' B M = ', I 1/)
FORMA TC'0 NUMBER OF EQUATIONS TO BE SOLVED= ',I2/'0 INITIAL TIME'
1 ' = ' , F4 .1 / '0 INITIAL STEP SIZE = '.F6.3/'0 TIME AT WHICH FIRST'
2' SOLU TION IS DEI SRED = ',F6. 3/'0 RELATIVE ER ROR BOUND= ',E9.2/
3·'0 METHOD = ',I 1/'0 ITERATIOH METHOD = ',I l/'0 INDEX = ', 12/
4'0 NUMBER OF CALLS TO DGEA R DESIRED= ',I4/
5'0 MAXIMUM NUMBER OF ITERATIONS DESIRED= ',I6///)
FORMA T(' ! THE EIGEN VLA UES ARE:',//'0',SCE11.4,5X)///
1'0 THE EIGENVECTO RS--COLU MN J CORRESPONDS TO EIGENVALUE J',
2//'0' ,SCS CE 11. 4 ,SX)//)///'0 INTEGRATION CONSTANTS:'//
3'0' , SCE11.4,S X))
FORMA Te' ',F8.3,I6,' PS ',6C1PE10.3 ,2X))
FORMAT(' ',F8.3,7C1PE10.3,2X),' PO ')
FORMATC' ',F8.3,2 X,lPE10.3, ' CHE ',4CE10.3,2X))
FO RMATC'0 THE INTEGRATION SUBROUTINE REACHED A TERMINAL ERROR AT'
1' T = ' , FB. 3/' 0 I ER = ', I 3/' 0 TOL = ' . FB. S/' 0 N = ', I 3/
2'0 XEN D = ',F9 .4/ '0 H = ', F10.S /' 0 METH = ',I3/'0 MITER= 'I3/
3' 0 INDEX = ', I3' 0 ITERATIONS = ',IS)
FORMA TC'0 PARAMETER VAL UES '// '0 VP1 = ',F6 . 2' ML' ,/'0 VP = ',F6.2
1' ~1L' ,/'0 VL = ', F6 . 2' ML' ,/'0 VF = ' , F6.2' GRA~1S' ,/' 0 VM = ',F6.2
2' GRAMS' , / '0 QL = ',F6.2' ML/MIN' ,/'0 QF = ',F6.2' ML/MIN'/'0 QM'
3'= 'F6.2' ML/MIN'/'0 PSPO = '1PE1S.5' / MIN'/'0 PSM = 'E1S.5' /MIN'
4/'0 POML = 'E1S.5' /M IN', /'0 POMP = 'E1S.S' ML/MIN',/'0 ACTV
SE 11. 4' UN ITS /CELL', /' 0 ACHED = ', E11. 4' U~l ITS' )
FORMATC '0 NRBC = '1PE11.4' CELLS'/'0 CHEO = ',E11.4' UNITS',/
1'0 SYN = '.E11. 4' UNITS/MIN',/'0 LIVER PROTEIN= ',E11.4
2' MICROI'lO L' ,/'0 PL ASt·lA PROTEIN= ',E11.4' f1ICROMOL'///)
FORMA TC' T = ',F8.3, SX . ' IER ='. I3' ITERATIONS = ',IS)
FORMATC'0 IER FOR EIGRF = ',I3/' 0 PERFORMANCE INDEX= ',F10.5///)
FORMiiT C'0 TH E PA RAOXON SYSTEM CONSTANTS'/)
FORMA TC'B',4C4C1PE1 5 . 5,5X)//))
FORMATC ' 0 KA = ' , 1PEIS.5,10X, ' I<G = ' , E15. 5/'0 THIS IS AN ORAL'
!'DOSE' )
FORMATC' B PSABSl = ',!PE15.5,!0X,'PSABS2 = '.E15.5/'0 THIS IS'
2' A DERMAL DOSE')
FORMATC'0 THE IV DOSE IS= ',1PE15.5)
FORMA TC'B THE ORAL DOSE IS = ', !PE 15.5)
FORMA TC'0 THE 1 COMPARTMENT DERMA L DOSE IS
1PE15.5)
FORMA TC'0 THE 2 COMPARTMENT DERMAL DOSE IS
IPE15.5)
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REAL LI FE.LIV.MSP.NRBC.ORAL, IV.KA1,KG2
INTE GER SWICH1,T IME.SW ICH 2
COMMON / ALL / SYN,VP,CAT,PSPO.CC16)
COMMON / CHEC/C l.C 2,C0 l ;CNH.C16
COMMON / DGER / AKI.AKR,CKI.CKR,PKR.PSL
COMMON / ACHEC/C50,ACHEP I ,CA 1, CA2,CA3 ,ACHEI.C15
COMMON / EVA L/VL,VF,VM,QL.QF,QM,PSM
COMMON /PARAt1S/POPL. POPP. AHl. CHI. FOP. LIFE. RAGE. CAGE
COMMON / GEAR / DUMtWC48), SDUMMYC4l. IDUMt1YC38l
COMMON / FCNS/ 8(6l,WRC6l.NUM.AC6,6l,SWICH2,XEND
DIMENSION YC 1ll,PSC6),EC6l.DC12),TIMESC13)
DIMENSION WKAREAC6), IWKC11l,WKC242)
COMPLEX ZC6,6l,WC6l.ZN
EXTE RNA L FCN.FCNJ
DATA ORAL/'ORAL'/,SKIN/'SKIN'/, IV/' IV'/
INPUT.DAT'.TYPE='OLD',ACCESS='SEQUENTIAL ',
lREADONLY,FORM='FORMA TTED',CAR RIAGECONTROL=' LI ST'l
C PARAMETER INPUT VA LUES
READC1,*lBW.LIV.FSP.FOP.MSP.PSPOI.PSMI,PO MLI.POMPI.
lPOPP. POPL . PKR
READCl.*lHCT,AACT.LIFE.AKI.R KR,SFP.SMP,OFP
READCl,*lATN.CACT.CKI . CKR.CAGE.CTN,AAGE,CAT
READC1.*lKAl,KG2.NOUT
READ CL 801 HYPE
WRITECNOUT,900lBW.LIV.FSP.FOP.MSP,PSPOI.PSMI.POMLI.POMPI.
lPOPP,POPL.PKR.HCT. AACT. LIFE.AKI.A KR.AAGE.ATN,CACT
WRITECNOUT.90llC KI.CKR,CAGE.CTN.SFP.SMP.OFP
IFCTYPE.EQ.ORALl WRITECNOUT,923lKA1.KG2
IFCTYPE.EO.SKIN) WRITE CNOUT.924lKA1.KG2
C PARATHION SYSTEM INITIAL STATES INPUT, IN MG/KG
READ C1. *l CPS C!) • I= 1. 6)
WRITE CNOUT. 902) CPS CIl, I= 1. 6)
OPEN CUN IT~1.NA ME='

PSC2l=PSC2l:t<8W/2~1.2?

C
C

C
C

C

C

C

5
C

PSCSl=PS CSl*BW/29) . 2?
PSC6l=PSC6l*BW/291.2?
IFCTYPE.EO.IVl WRITECNOUT.925lPSC2l
IFCTYPE.EQ.ORALl WRITECNOUT.926lPSC6)
IFCTYPE.EQ.SKIN.AND.PSC5l.NE.0.0) WRITECNOUT,92?lPSC5l
IFCTYPE.EO.SKIN.AND.PSC6l.NE.0.0l WRITECNOUT,928lPSC6l
PARAOXON SYSTEM INITIAL INPUTS
READ C1. 803) CYC I ) . I= 1. 11)
WRITE CNOUT . 903) CYC I), I= 1. 11l
EVALUATE PARAMETERS
CALL PARAMCBW.LIV,PSPOI,PSMI.POMLI,POMPI.AACT,HCT.CACT,
1VP1.POML .POMP.ACTV.ACHEO.NRBC.CHEO.Y.AKI. AKR.CKR.CK I.OFPl
WRITE CNO UT. 916) VP 1, VP, VL, VF, VM. OL. OF, OM. PSPO, PSM, POML. POMP, ACTV,
1ACHEO
WRITECNOUT,919lNRBC.CHEO.SYN.YC3l.YC5l
PROGRAM SWITCHES; ,IF PS SY;STEM IS TO BE SOLVED,S WICH1=1; IF THE SOLVED
SYSTEM IS TO BE INPUT. SWICH 1=0; IF PS (5) =0. 0, AT 12 HOURS. SWICH2= 1
READCl,*lSWICHl.SWICH2
WRITECNOUT,904lSWICHl,SWICH2
IFCSWICHl.E0.0lGO TO 1100
EVALUATE PS SYSTEM PARAMETERS AND FORM COEFFICIENT MATRIX A
IFCTYPE.EQ.ORALl CALL PSSYS3CFSP.MSP.SFP.SMP.KA1. 1< G2.D,Al
IFCTYPE.EO.SKINl CALL PSSYSCFSP.MSP.SFP.SMP.KAl.KG2.D.Al
LJRITECNOUT.905l CCACI.Jl.J=1.6l. I=1.6l
WRITE CNOUT. 921)
WRITE CNOUT. 922) CCC I) .. I= 1. 16)
COMPUTE EIGEN VA LUES AND EIGENVECTORS FOR COEFFICIENT MATRIX 'A'
READ( 1,805) IA. IZ.N. IJOB
NUM=N
CALL EIGRFCA ,N.IA.IJOB,W,Z.IZ. WK.IERl
WRITE CNOUT, 906) CW( Il. I= 1. Nl
NORMALIZE EIGEN VECTORS
DO 5 J=LN
BCJl=PSCJ)
ZN=ZC l,J)
DO 5 I= l.N
ZCI,Jl=ZCI.Jl/ZN
ACI,Jl=REALCZCI.Jl)
CONTINUE
WRITE THE EIGEN VA LUE MATRIX
WRITE ( NOUT. 907l ( CZ CI. J). J= 1. 6), I= 1. Nl
WRITE (!~OUT, 920) IER, WK C1)
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C CHECK FOR IMAGINARY OR MULTIPLE EIGENVAlUES.STOP PROGRAM IF ANY ARE FOUND
C PUT REAL PART OF EIGENVALUE INTO WR
CALL RTCHEKCW.NUM.L.WR)
IFCL.EQ.0)G0 TO 1000
WRITECNOUT.908)L
GO TO 1400
C SOLVE FOR INTEGRATION CONSTANTS CX) BY EVALUATING AX=B CB=PS INITIAL STATES)
1000
IER=0
READC L806)M, IDGT
CALL LEQT!FCA,M.N. !A.B. IDGT,WKAREA. IERl
WRITECNOUT.909)(8Cll,I=1,6),IER.IDGT,M
IFCIER.GT.l27)G0 TO 1400
GO TO 1200
C INPUT EIGENVALUES, EIGENVECTORS, AND INTEGRATION CONSTANTS FOR SOLVED
C PS SYSTEM
1 I 00
READ CL 808) CWR CD • I =L 5) • CCZCL J) • J =L 5) • I =1. 5) , CBCD • I =1. 5)
WR ITECNOUT,911l CWRC!), I= 1.5). CCZC LJ). J= 1.5), I=L5). CBC!). I=1.5)
1200
DO 15 I=L35
15
WK(!)=0.0
C INPUT PARAMETERS FOR CONTROLLING THE INTEGRATION SUBROUTINE
READC1.*lN.X,H,XEND,TOL.TOL2,METH.MITER.INDEX,IQUIT.TIME.
READC L*) CTIMESC D. I=1.8)
READ C1. *) CTIMES C!), I =9, 13)
WRITE CNOUT.910)N.X.H,XEND.TOL,METH,MITER,INDEX.TIME,IQUIT
CLOSE CUN IT= I)
OPENCUNIT=2.NAME='OUTPUT.DAT'.TYPE~'NEW' .ACCESS='SEQUE~ITIAL',

lFORM='PORMATTED',CARRIAGECONTROL='LIST')
C PUT EIGENVECTORS INTO MATRIX A
DO 20 I= 1, NUM
DO 20 J=LNUM
20
ACI.J)=REALCZCI,J))
C FUNCTION EVALUATION LOOP
DO 55 K= L TIME
XEN.D2= XEND
IF CSW IC H2 .EQ. l.AND. XEND . GT.720.0) XEN D2=XE ND-720.0
C EVALUATE C*E**LAMBDA*TIME, X=TIME; COMPUTE PS STATE VARIABLES
DO 25 I= LNUM
PS (I) =0. 0
25
E C!) =B ( D *EXP CWR C!) *XEND2)
DO 30 I=L NUM
DO 30 J=LNUM
30
PSCil=ECJ)*ACI,J)+PSCI)
C EVALUATE PO SYSTEM; IF INTEGRATION SUCCEEDS. WRITE RESULTS TO AN OUTPUT
C FILE; IF INTEGRATION FAILS. STOP THE PROGRAM
CALL DGEARCN,FCN.FCNJ,X,H.Y.XEND,TOL,METH.MITER.rNDEX. IWK.WK.IER)
IFCIER.GT.128)G0 TO 1250
IFCIER.GE.33.AND.IER.LE.67)WRITECNOUT,917)X, IER.IDUMMYC7)
LJR ITE C2. 912) X, IDU11MYC7). CPS CD. I= 1, NUt1)
LJR ITE C2. 9 13) X. CYC1) • I= L 7)
WRITE C2. 914) X. PSL. CYC!). I =B. t·D
IFCIDUMMYC?).GT.IOUITlGO TO 1300
C CHANGE PSC5) TO 0.0 IF SWICH2=1 AND XEND=12; COMPUTE XEND
IFCSWICH2.NE. I.OR. XEND.NE.720.0) GO TO 54
INDEX=-!
TOL=TOL2
DO 31 I=L4
31
8 ( I) =PS C!)
8(5)=0.0
NOW=4
CALL LEQTIFCA.M.NOW.IA,B.IDGT,WKAREA.IER)
DO 33 I= L5
DO 33 J=LS
33
ACI,J)=REALCZCI,J))
WRITE CNOUT. 909) CB C!). I= L NU ~1)
54
CALL ENDTIMC XEND . TIMES)
ICOUtH=K
55
CONTINUE
GO TO 1300
C DIAGNOSTICS FOR IER.GT. 120
1250
WRITECNOUT,915)X,IER.TOL.N.XEND.H.METH.MITER.INDEX.IDUMMYC7)
WRITE CNOUT, 912) X, CPS C!). I= L HUM)
WRITE CI~OUT. 913) X. CYC!). I= L 7)
WRITE C~lDU T. 914) X. CY CI) . I =8 . N)
1300
CLOSE CUN IT=2)
LJR ITE CI·lO UT. *) ICOU ~H
1400
STOP
EHD
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SUBRO UTINE PARAMCBW,LIV.PSPOI.PSMI.POMLI,POMPI.AACT,HCT,CACT,
1VP1,POML,POMP , ACTV,ACHEO,N RBC, CHEO,Y,AKI,AKR,CKR,CKI,OFP)
REAL LIFE.LI V,NRBC
COMMON/ALL / SYN. VP.C AT.P SPO .CC16)
COMMON/EVA L/VL, VF.VM,QL,QF,QM,PSM
COMMON/PARAMS/POP L.POPP,ATN,CTN.FOP,LIFE,AAGE,CAGE
DIMENSION YC 11)
C PARA METER EVALUATIONS
VP 1=. 0413*BlJ
VP =VP l/0. 78
VL=LIV*0.75*34*CCBW/1000)**0.87)
VF =0. 10*BlJ
VM=0.455*BW
QL=C2820*C<BW/1000)**0.87*0.6))/(60*1.05*0.78)
QF= (0 . 6*124*( CBW/1000) **B . 84)) / ( 1. 05*60*0. 78)
Qt-1=(0.6*1484*( CBLJ/1000)**0.85) )/( 1.05:!<60*0. 78)
PSPO=PSPOI *C QL/VL)
PSM=PSMI*COL/VLl
POML=POMLI*CQL/VLJ
POMP=POMPI*VP1
ACTV=HCT*AACT/8.9E+09
ACHEO=AACT*CVP1>kCHCT/(1-HCTJJ)
NRBC=8 .9E+09 >kCVP 1/(1-0 .46J )
CHEO=CACT*VP 1
SYH=CAT*CHEO
C INITI AL COND ITIONS
YC3)=YC3)>kVL
YC5J=YC5l*VP t
YCB)=ACHEO
YC10)=CHEO
C EVALUATE COHSTA~lTS FOR PARAOXON SYSTEM
C( 1J =QL/VL +POML
CC2J=POPL/VL
CC3)=QL/VP
CC4J=QL/VL
CC5J= CC3 J+POMP /VP+CQF/VPl *OFP
CC6J =POPP/VP
C(?) =Af< I/ATN
[(8)=0.0
CC9J=CKI/CTN
CC10J=0.0
CC11J=CQF/VPJ >k0FP
CC12 J= (Q F*FOPJ/VF
CC13J=CNRBC*ACTVJ/LIFE
CC1 4J =C C13)/ACHEO
CC15J=AKR+AAGE+CC14)
CC16) =CKR+U1GE +CAT
RETU RN
END

C

28
C

25

SUBROUTINE RTCHEKClJ.NUM,L,lJR)
CHECK FOR MULTIPLICITY OF EIGENVALUES
COMP LE X lJCNUM)
DIMENSION WRCNUM)
L=B
DO 20 I=l,CNUM-1)
DO 20 J=I+LNUM
IFClJ(l) .EQ.lJ(J))L=l
CONTINUE
CHECK FOR IMAGINARY ROOTS
DO 25 I =LNUM
IF(AIMAGClJCI)).NE.0)L=l
lJR(!) =REALClJ( I))
CONTINUE
RETURN
END

SUBROUTINE FCNCN,X,Y,YPRIMEl
C THE DIFFERENTIAL EQUA TI ONS FOR THE PARAO XON · SYSTEM
COMMON/ALL/SYN,VP, CAT,PSPO ,CC16 l
COMMON/DGER/AK I,AK R, CKI.CKR,PKR,PSL
COMMON/FCNS/8(6l,WRC6 l,NUM.AC6.6l.SWICH2.XEND
REAL YCNl.YPRIMECNl
INTEGER SLJi CH2
PSL=El.0
X2=X
IFCSW!CH2.EQ. 1.AND. XEND.GT.720.0l X2 =X-720.0
DO 205 I= 1. NUM
205
PSL=PSL+B C1) *EXP ClJRC D*X2l *A ( 1. D
DO 10 I= 1. 11
10
IFCYCil.LT.0.0l '((1) =0.0
C100=CAKI/VPl*YC2l
C181 =CCI< l/VPl *YC2l
YPR It1E C1) =PSPO *PSL- CCC 1HC C2) *YC3l) *YC 1) +C (3) *YC2)
YPRIME C2l =CC4l *YC1 l-CCC 5l +CC6l *YC 5l+CC7l*YC8l
1+CCC9 l*Y C10lll *YC2l+CC12l *Y C7l
YPRIMEC3)=-CC2l *YC 1l *YC3l+PKR*YC4)
YPRIMEC4l=-YPRIMEC3l
YPRIMEC5l=-CC6l*YC2l*Y C5l+PKR*YC6l
YPRIMEC6l=-YPRIMEC5l
YPRIMEC7l=CC11l*YC2l-CC12l*YC7l
YPRIMEC8l=CC13l-CC100+CC14ll *Y C8l+AKR*YC9l
'r'PR It1EC9l =C 10El*YC8l -C C15) *Y(9)
YPRIt1E C10) =S'r'N- CCAT+C 101 l ::,y( 18l +CI<R*YC 1\ l
YPR I ME C11 l =C 10 1*Y C10 l -C C16 l *Y ( 11 l
RETURN

am

SUBROUTIN~ FCNJCN.X.Y.PD)
C JACOBIAN MATRIX OF PARTIAL DERIVATIVES
COMMON/ALL/SYN.VP.CAT.PSPO.CC16l
COMMON/DGER/AKI.A KR.CKI,CKR.PK R.PSL
REAL YCNl.PDCN,Nl
DO 10 I= 1. 11
10
IFCYC D .L T.0. 0) YC D =0.0
C100=CAKI/VPl *YC2l
C101=CCKI/VPl *Y C2l
PD C1. ll =-CCC 1l+C C2l *Y C3l)
PDC1.2l=CC3l
PDC1.3 l =-CC2l*YC1l
PDC2.1l =CC4l
PDC2,2l=-CC5l-CC6l*YC5l-CC7l*YC8l-CC9l*YC10l
PD C2.5l=-CC6l*YC2)
PDC2.7l=CC12l
PDC2.8l=-CC7l *YC2 l
PD C2 . 10) =-YC2l *C(9)
PD (3 , 1l =-C C2l *YC3l
PDC3.3)=-CC2l*YC1l
PD C3. 4) =PI<R
PD C4. ll =-PD C3. 1)
PDC4.3l=-PDC3.3l
PD C4. 4) =-PI<R
PD C5.2l=-CC6l li<Y C5l
PD C5. 5l =-C C6H<YC2l
PDC5.6l=PKR
PDC6.2 l =-PDC5.2l
PD C6. 5l =-PD C5 . 5)
PDC6.6l=-PKR
PD C7. 2) =C C11l
PDC7.?l=-CC12)
PDC8.2)=-AK I/VP*YC8l
PD C8.8l=-CC100+CC14ll
PDC8,9l=A KR
PDC9.2l=-PDC8.2l
PDC9 . 8l=C100
PD C9. 9) =-C C15 )
PDC10.2l=-CCKI/VPl*YC10l
PDC10,10l=-CCAT+C101l
PDC 10.11) =CKR
PDC11.2 l =-PDC10,2)
PD C11.10) =C101
PD C11.11l=-C C16l
RETURN
Etm

C THIS SUBROUTINE IS USED TO SET UP THE COEFFICIENT MATRIX FOR THE PARATHION
C SYSTEM WHEN AN ORA L DOSE IS GIVEN
SUBROUTINE PSSYS3 CFSP . 11SP, SFP, SMP, I<A, I<G, D, A)
REA L MSP,I<A ,I<G
COMMON/ALL/SYN , VP,CAT,PSPO , CC16)
COMMON/EVAL/VL.VF,VM,QL, QF.QM,P SM
DIME NSION DC1 2 l ~ AC6,6)
C PS SYSTEM PARAMETERS
DC 1) =QL/VL
DC2 l=PSPO+PSM+DC1l
DC3l =QL/VP
DC 4l =QF/ 1./P
DC5l=QF/VF
DC 6 l =011/VP
DC ?l =QM/VM
DC 8 l=D C5l li<FSP
DC9 ) = DC() >1<115 P
DC 10) =D (4) )t< SF P
DC11 ) = DC6) )t<SMP
·DC12) =D C3H-D C10HD Clll
C COEFFICIENT MATR IX A FOR PS SYSTEM CX'=AXl
AC L 1) =-D C2)
AC L2l,DC3l
riC L 5l =KA
AC 2. 1) =DC 1)
AC2 . 2l=- DC12l
AC2 ,3 )=D C8l
AC2,4 )= DC9)
AC3,2l=DC10l
~/·
AC3.3 ) =-D C8)
AC4.2l=DC11)
AC4.4l=-DC9)
AC5. 5) =-KA
A C5 . 6) =KG
fi C6 , 6) =-I<G
RETU RN
END

SUBROUTINE PSSYSCFSP,MSP,SFP,SMP,PSABS1,PSABS2,D,Al
REA L MSP
COMMON / AL L/S YN,VP,CAT,PSPO,CC16l
COMMON / EVAL/VL,VF , VM.Q L, QF,QM,PSM
DI MENSI ON DC12l.AC6,6)
C PS SYSTEM PARm1ETERS
DC1l =QL/VL
DC2l=PS PO+PSM+DC 1)
DC3l=QL/VP
DC4)=QF/VP
DC5l=QF/VF
DC6) =QI1/VP
DC?)=QM/VM
DC8l=DC5l *FSP
D C9) = D (?) >t<MS P
DC10l=DC4l*SFP
DC1 1l = D C6) )J<S MP
DC12l=DC 3 l+DC10l+DC11)
C COEFFICI EN T MATRIX A FOR PS SYS TEM CX'=AXl
ACL1l=-DC2)
ACL2l =DC3)
AC 2, 1l =DCll
AC2,2l =- DC 12)
AC2,3l=DC8l
AC2,4l=DC9)
AC2.5l=PSABS2
AC3,2l=DC10)
AC3,3l=-DC8)
AC4.2) =DC 11)
AC4,4)=-DC9)
AC5,5l=-P3ABS2
AC5.6l=P SA8S l
AC6,6)= - PSABS1
RETURN
EHD

C
C
C
C
C

THIS SUBROUTINE COMPUTES XEND FOR SUBROUTINE DGEAR USED IN CHESIM.TSK
TIMESC1-8) ARE THE ENDING TIMES IN DESCENDING ORDER WHICH ARE USED TO
DECIDE HOW MUCH TO INCREASE XEND
Tit1ES C9-13) ARE THE AMOUNTS BY LJHICH XEND IS INCRESED
UNUSED TIMES SHOULD BE FILLED IN WITH ZEROES
SUBROUTINE ENDTIMCXEND,TIMES)
DIMENSION TIMESC13)
IF CXEND. GE. TIMES (8)) XEND= XEND+TIMES (9)
IF CXEND. GE. TIMESC6). AHD. XEND. LE. TIMES (7)) XEND=XEND+TIMESC lED
IF CXEND . GE.TI MES C4). AN D. XEH D.LE.TI MES C5)) XE HD=XEND+TIMESC11)
IF CXEND. GE. TI MES C2). AN D. ><END. LE. TI MES C3)) XEND= XEND+TIMES C 12)
IF CXEND.L E.TIMESC1)) XE ND= XEHD+TI MESC 13)
RETURN
END

C
C
C
C
C
C
C
C
C

THIS PROGRAM MAKES A PRINTER PLOT OF THE OUTPUT FROM CHESIM IN OUTPUT.DAT
THE CONTROLLI NG PARAMETERS ARE INPUT FROM PLOT.DAT
UGETIO AND USPLT SU BROUTINES FROM IMSL-? ARE USED
ILOG=1: PLOT LOG TI ME
N=NUMBER OF TI ME POINTS TO BE READ AND PRINTED
NPLOT=NU MBER OF TI ME POINTS TO BE PLOTTED
ISWICH=0: PLOT ALL THREE GRAPHS
ISWICH=1: SKIP THE CHE INHIBITION DATA
ISWICH=2: SKIP THE PS AND PO DATA
DIMENSION IMAG4C5151), !TITLE ( 144), !CHAR ( 10), XC 100), YC 100, 4),
1RANGEC4)
DATA ICHAR(l)/' '/
OPENCUNIT=l,NAME='PLOT.DAT',TYPE='OLD',ACCESS='SEQUENTIAL',
1READONLY,FORM='FORMATTED',CARRIAGECONTROL='LIST')
800
FORMATC?2A 1)
FORMATC/F8.3,3?X,E10.3,12X, E12.3/26X,E10.3,12X,E12.3)
801
FORMATCF8.3,11 X,E10.3,3E12.3//)
802
FORMATC / F8.3,1X,510.3,E12.3,50X,E10.3/)
803
FORMATC' 8 TI ME', 12X' ACHE', 1?X' CHE', 16X' ESTLP', 16X' ESTPP')
900
901
FORMATe' 0', F6. L 1PE20. 5, 3CE20. 5))
902
FORMATe' 1 TIME' . 14X'PSL', 1?X'PSP', 1?X' PSF', 16X'PSMU')
904
FOR t'lATC' 1 TI ME', 14X'POL', 1?X'POP', 1?X' POF')
FORMATC'0',F6.1,1PE 20.5:2 CE20.5))
905
C THE FOLLOWING INPUT PARAMETE RS WILL CHANGE WHEN THE RAT WEIGHT CHANGES
READC1, * l VL,VP,VF, VM,ACHEO,CHEO,ESTLO,ESTPO
ACHE=1 00.0/ ACHEO
CHE=l00.0/CHEO
ESTL=100.0/ESTLO
ESTP=100.0/ESTPO
VLC=l.0/VL
VPC= 1. 0/VP
VFC= 1. 0/VF
VMC=1. 0/VM
READC1,*)ISWICH,ILOG,ISTART,NIN,NOUT
READ CL 800) C!TITLE C!), I=L ?2)
READCL800) CITITLEC!), !=?3, 144)
READCL*) INC,N,NPLOT,M, !OPT, IY, CRANGECIJ, I=L4)
XC1)=0 . 0
DO 3 I=L4
3
YCLD=100.0
OPENCUNIT=2,NAME= ' OUTPUT.DAT',TYPE='OLD',ACCESS='SEQUENTIAL',
1READONL Y, FORM=' FORMA TIED · , CARR I AGECONTROL ='LIST' )
CALL UGETIOC3.NIN.NOUT)
IFCISWICH.EQ.1) GO TO 200
DO 10, I=ISTART,N
C READ ESTLP,ESTPP,ACHE,CHE
READ C2. 801) X(!), YC L 3). YC L 4). YC L 1), YC I. 2)
YC I. 1) =YC L U*ACHE
YCI,2)=YCI,2)*CHE
YCI,3)=100.0-YCI ~ 3) *ESTL

10

YCI.4)=100.0-YCI,4)*ESTP
IFCILOG.EQ.1)XCI)=ALOG10CXCI))
CONTIN UE

72.

WR ITE ( NOUT, 900)
DO 100 I=LN
100
WRITECNOUT,90DXCD,YCL D,YCL2),YCL3),YCL4)
CALL USPL TCX, Y. IY, NPLOT.I1, INC, I TITLE. RANGE. I CHAR, !OPT, IMAG4, IER)
IFCISWICH.EQ.2) GO TO 210
REWIND 2
200
READ C1, 800) CITITLE C!). I= L 72)
READ< L 800) <ITITLE C!). I =73, 144)
READ<L*)M. CRANGECI), I=L4)
DO 4 I=L4
4
YC L!) =0. 0
DO 15 I=ISTART,N
C READ PSL,PSP,PSF,PSMU
READ C2, 802) X<!) . YC L D, YC L 2), YC L 3), YC L 4)
YC L 1) =YC L 1) *VLC
YCI,2)= YCI,2)*VPC
YCI,3)=YCI,3)*VFC
YCI,4)=YCI,4)*VMC
IF CILOG. EO. 1) XC!) =ALOG 10 CXC!))
15
CONTIN UE
WRITE CNOU T. 902)
DO 110, I=LN
1 10
WR ITE CNOUT. 981) XC !) • YCI. 1) • Y CI. 2 ) • Y CL 3) • YCI. 4)
CALL USPLTCX,Y.IY.~IPLOT,M.INC. ITITLE.RANGE,ICHAR,IOPT,IMAG4,IER)
REWIND 2
READ CL 800) CITITLEC!) .. I =L 72)
READ ( L 800) ( ITITLE C!), I "'73, 144)
READCL*)M, CRANGECD, I=L4)
DO 20 I=ISTART.N
C READ POL,POP.POF
READC2,803)XC!), YC I. 1), YC 1.2), YC !,3)
YC I,1) ~YC I. D>!<VLC
YCI,2)=YCI,2)*VPC
YCI,3)=YCI,3)*VFC
IF CILOG. EQ. 1) XC!) =ALOG HHXC I))
20
CONTINUE
WRITECNOUT,904)
DO 120 I=L N
120
LJR ITE CNOUT, 905) XC!) , YC L D, YC L 2), YC L 3)
CALL USPL TCX, Y, IY. ~!PLOT. M. INC, !TITLE, RANGE, !CHAR, !OPT, IMAG4, IER)
210
CLOSECUNIT=1)
CLOSE CUt'IIT=2)
END

,...

